Thanks for visiting Scientific Computing World.

You're trying to access an editorial feature that is only available to logged in, registered users of Scientific Computing World. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Optibrium and Cresset announce technology exchange

Share this on social media:

Optibrium, a provider of software solutions for drug discovery, and software and services provider Cresset, will be collaborating on the development of next-generation platforms. The two companies will combine their unique approaches to help drug discovery projects quickly identify novel, potent compounds with a high chance of success downstream.

The collaboration will involve a two-way exchange of technologies. Optibrium’s ADME models, currently provided as a plug-in module for its StarDrop software platform, will be made available to users of Cresset’s desktop applications. Similarly, Cresset’s FieldAlign software, which helps chemists understand the three-dimensional structure-activity-relationship of their chemistry in order to design active compounds, will be available as an optional plug-in module for StarDrop. StarDrop aids project teams in confidently targeting compounds with a good balance of properties for their therapeutic objectives.

Achieving a combination of potency with appropriate ADME and safety properties is essential to the discovery of high-quality drug candidates. Cresset’s molecular field technology provides insight into the biological activity, properties and interactions of molecules, which enables biologically meaningful comparisons that are not limited by two-dimensional structures.